Table 3. Adverse events observed during the study of voglibose/metformin fixed-dose combination (FDC) and coadministered metformin and voglibose in healthy Korean subjects.

System organ class   Preferred term	Voglibose/metformin FDC† (n = 28)	Co-administered voglibose and metformin† (n = 28)
Gastrointestinal disorders
Loose stools	3 (3)‡	3 (3)‡
Epigastric discomfort		1 (1)‡
Periodontitis	1 (1)
Body as a whole/general disorders
Fever	1 (1)
Total (adverse events)	5 (5)	4 (3)
Total (adverse drug reactions)	3 (3)	4 (3)

^†Data represents number of cases (number of subjects); ^‡Considered to be study drug-related.